Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

Phase 2 Unknown 200 enrolled Sun Yat-sen University

RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective, randomized, controlled clinical trial will evaluate the effect and security of dexamethasone prevention for Patients of Ovarian Hyperstimulation Syndrome.

Timeline

Start: 2016-08
Primary completion: 2018-06
Completion: 2018-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Bromocriptine	Small molecule	2.5 mg	Rectal
Subject	Dexamethasone	Small molecule	3 mg	Oral

Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

Summary

Timeline

Drugs

Indications